The Combination Options and Predictive Biomarkers of PD-1/PD-L1 Inhibitors in Esophageal Cancer.

Front Oncol · 2020 · PMC7066251 · PMID 32195194

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

Combination With ICIs Since the different mechanisms of ICIs, the combination of PD-1/PD-L1 inhibitors with other ICIs may be significant.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.